Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

  FDsys > Browse By Collection > Collection Results > More Information
(Search string is required)
 

21 CFR 520 - ORAL DOSAGE FORM NEW ANIMAL DRUGS


Download Files

Metadata

Document in Context
   
Expand    Title 1 - General Provisions
Parts 1 - 500. January 1, 2001.
Expand    Title 3 - The President
Parts 100 - 102. January 1, 2001.
Expand    Title 4 - Accounts
Parts 2 - 83. January 1, 2001.
Expand    Title 5 - Administrative Personnel
Parts 1 - 8701. January 1, 2001.
Expand    Title 7 - Agriculture
Parts 1 - 4287. January 1, 2001.
Expand    Title 8 - Aliens and Nationality
Parts 1 - 507. January 1, 2001.
Expand    Title 9 - Animals and Animal Products
Parts 1 - 500. January 1, 2001.
Expand    Title 10 - Energy
Parts 1 - 1800. January 1, 2001.
Expand    Title 11 - Federal Elections
Parts 1 - 9039. January 1, 2001.
Expand    Title 12 - Banks and Banking
Parts 1 - 619. January 1, 2001.
Expand    Title 13 - Business Credit and Assistance
Parts 101 - 500. January 1, 2001.
Expand    Title 14 - Aeronautics and Space
Parts 1 - 1299. January 1, 2001.
Expand    Title 15 - Commerce and Foreign Trade
Parts 0 - 2301. January 1, 2001.
Expand    Title 16 - Commercial Practices
Parts 0 - 1750. January 1, 2001.
Expand    Title 17 - Commodity and Securities Exchanges
Parts 1 - 450. April 1, 2001.
Expand    Title 18 - Conservation of Power and Water Resources
Parts 1 - 1317. April 1, 2001.
Expand    Title 19 - Customs Duties
Parts 1 - 357. April 1, 2001.
Expand    Title 20 - Employees' Benefits
Parts 1 - 1001. April 1, 2001.
Collapse    Title 21 - Food and Drugs
Parts 1 - 1499. April 1, 2001.
Toc - Table Of Contents
Collapse
Chapter I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES-Continued (Parts 1 - 1299)
Toc - Table Of Contents
Toc - Table Of Contents (Parts 520 - 520)
Section 520.23 - Acepromazine maleate tablets.
Section 520.44 - Acetazolamide sodium soluble powder.
Section 520.45 - Albendazole oral dosage forms.
Section 520.45a - Albendazole suspension.
Section 520.45b - Albendazole paste.
Section 520.48 - Altrenogest solution.
Section 520.62 - Aminopentamide hydrogen sulphate tablets.
Section 520.82 - Aminopropazine fumarate oral dosage forms.
Section 520.82a - Aminopropazine fumarate tablets.
Section 520.82b - Aminopropazine fumarate, neomycin sulfate tablets.
Section 520.88 - Amoxicillin oral dosage forms.
Section 520.88a - Amoxicillin trihydrate film-coated tablets.
Section 520.88b - Amoxicillin trihydrate for oral suspension.
Section 520.88c - Amoxicillin trihydrate oral suspension.
Section 520.88d - Amoxicillin trihydrate soluble powder.
Section 520.88e - Amoxicillin trihydrate boluses.
Section 520.88f - Amoxicillin trihydrate tablets.
Section 520.88g - Amoxicillin trihydrate and clavulanate potassium film-coated tablets.
Section 520.88h - Amoxicillin trihydrate and clavulanate potassium for oral suspension.
Section 520.90 - Ampicillin oral dosage forms.
Section 520.90a - Ampicillin capsules.
Section 520.90b - Ampicillin trihydrate tablets.
Section 520.90c - Ampicillin trihydrate capsules.
Section 520.90d - Ampicillin trihydrate for oral suspension.
Section 520.90e - Ampicillin trihydrate soluble powder.
Section 520.90f - Ampicillin trihydrate boluses.
Section 520.100 - Amprolium oral dosage forms.
Section 520.100a - Amprolium drinking water.
Section 520.100b - Amprolium drench.
Section 520.100c - Amprolium crumbles.
Section 520.110 - Apramycin sulfate soluble powder.
Section 520.154 - Bacitracin oral dosage forms.
Section 520.154a - Soluble bacitracin methylene disalicylate.
Section 520.154b - Soluble bacitracin methylene disalicylate and streptomycin sulfate oral powder.
Section 520.154c - Bacitracin zinc soluble powder.
Section 520.182 - Bicyclohexylammonium fumagillin.
Section 520.222 - Bunamidine hydrochloride.
Section 520.246 - Butorphanol tartrate tablets.
Section 520.260 - n-Butyl chloride capsules.
Section 520.300 - Cambendazole oral dosage forms.
Section 520.300a - Cambendazole suspension.
Section 520.300b - Cambendazole pellets.
Section 520.300c - Cambendazole paste.
Section 520.309 - Carprofen.
Section 520.310 - Caramiphen ethanedisulfonate and ammonium chloride tablets.
Section 520.312 - Carnidazole tablets.
Section 520.314 - Cefadroxil tablets.
Section 520.315 - Cefadroxil powder for oral suspension.
Section 520.390 - Chloramphenicol oral dosage forms.
Section 520.390a - Chloramphenicol tablets.
Section 520.390b - Chloramphenicol capsules.
Section 520.390c - Chloramphenicol palmitate oral suspension.
Section 520.420 - Chlorothiazide tablets and boluses.
Section 520.434 - Chlorphenesin carbamate tablets.
Section 520.445 - Chlortetracycline oral dosage forms.
Section 520.445a - Chlortetracycline bisulfate/sulfamethazine bisulfate soluble powder.
Section 520.445b - Chlortetracycline powder (chlortetracycline hydrochloride or chlortetracycline bisulfate).
Section 520.445c - Chlortetracycline tablets and boluses.
Section 520.446 - Clindamycin hydrochloride capsules.
Section 520.447 - Clindamycin hydrochloride liquid.
Section 520.452 - Clenbuterol syrup.
Section 520.455 - Clomipramine hydrochloride tablets.
Section 520.462 - Clorsulon drench.
Section 520.530 - Cythioate oral liquid.
Section 520.531 - Cythioate tablets.
Section 520.534 - Decoquinate.
Section 520.540 - Dexamethasone oral dosage forms.
Section 520.540a - Dexamethasone powder.
Section 520.540b - Dexamethasone tablets and boluses.
Section 520.540c - Dexamethasone chewable tablets.
Section 520.550 - Dextrose/glycine/electrolyte.
Section 520.563 - Diatrizoate meglumine and diatrizoate sodium oral solution.
Section 520.580 - Dichlorophene and toluene capsules.
Section 520.581 - Dichlorophene tablets.
Section 520.600 - Dichlorvos.
Section 520.608 - Dicloxacillin sodium monohydrate capsules.
Section 520.620 - Diethylcarbamazine oral dosage forms.
Section 520.622 - Diethylcarbamazine citrate oral dosage forms.
Section 520.622a - Diethylcarbamazine citrate tablets.
Section 520.622b - Diethylcarbamazine citrate syrup.
Section 520.622c - Diethylcarbamazine citrate chewable tablets.
Section 520.622d - Diethylcarbamazine citrate capsules.
Section 520.623 - Diethylcarbamazine citrate, oxibendazole chewable tablets.
Section 520.645 - Difloxacin.
Section 520.763 - Dithiazanine iodide oral dosage forms.
Section 520.763a - Dithiazanine iodide tablets.
Section 520.763b - Dithiazanine iodide powder.
Section 520.763c - Dithiazanine iodide and piperazine citrate suspension.
Section 520.784 - Doxylamine succinate tablets.
Section 520.804 - Enalapril tablets.
Section 520.812 - Enrofloxacin tablets.
Section 520.813 - Enrofloxacin oral solution.
Section 520.816 - Epsiprantel tablets.
Section 520.823 - Erythromycin phosphate.
Section 520.863 - Ethylisobutrazine hydrochloride tablets.
Section 520.870 - Etodolac.
Section 520.903 - Febantel oral dosage forms.
Section 520.903a - Febantel paste.
Section 520.903b - Febantel suspension.
Section 520.903c - [Reserved]
Section 520.903d - Febantel-praziquantel paste.
Section 520.903e - Febantel tablets.
Section 520.905 - Fenbendazole oral dosage forms.
Section 520.905a - Fenbendazole suspension.
Section 520.905b - Fenbendazole granules.
Section 520.905c - Fenbendazole paste.
Section 520.905d - Fenbendazole powder.
Section 520.905e - Fenbendazole blocks.
Section 520.960 - Flumethasone tablets.
Section 520.970 - Flunixin oral dosage forms.
Section 520.970a - Flunixin meglumine granules.
Section 520.970b - Flunixin meglumine paste.
Section 520.1010 - Furosemide oral dosage forms.
Section 520.1010a - Furosemide tablets or boluses.
Section 520.1010b - Furosemide powder.
Section 520.1010c - Furosemide syrup.
Section 520.1044 - Gentamicin sulfate oral dosage forms.
Section 520.1044a - Gentamicin sulfate oral solution.
Section 520.1044b - Gentamicin sulfate pig pump oral solution.
Section 520.1044c - Gentamicin sulfate soluble powder.
Section 520.1100 - Griseofulvin.
Section 520.1120 - Haloxon oral dosage forms.
Section 520.1120a - Haloxon drench.
Section 520.1120b - Haloxon boluses.
Section 520.1130 - Hetacillin oral dosage forms.
Section 520.1130a - Hetacillin potassium capsules.
Section 520.1130b - Hetacillin potassium oral suspension.
Section 520.1130c - Hetacillin potassium tablets.
Section 520.1157 - Iodinated casein tablets.
Section 520.1158 - Iodochlorhydroxyquin boluses.
Section 520.1182 - Iron dextran oral suspension.
Section 520.1192 - Ivermectin paste.
Section 520.1193 - Ivermectin tablets and chewables.
Section 520.1194 - Ivermectin drench.
Section 520.1195 - Ivermectin liquid.
Section 520.1196 - Ivermectin and pyrantel pamoate chewable tablet.
Section 520.1197 - Ivermectin sustained-release bolus.
Section 520.1204 - Kanamycin sulfate, aminopentamide hydrogen sulfate, pectin, bismuth subcarbonate, activated...
Section 520.1205 - Kanamycin sulfate, pectin, bismuth subcarbonate, activated attapulgite tablets.
Section 520.1242 - Levamisole hydrochloride oral dosage forms.
Section 520.1242a - Levamisole hydrochloride drench and drinking water.
Section 520.1242b - Levamisole hydrochloride tablet or oblet (bolus).
Section 520.1242c - Levamisole hydrochloride and piperazine dihydrochloride.
Section 520.1242d - Levamisole resinate.
Section 520.1242e - Levamisole hydrochloride effervescent tablets.
Section 520.1242f - Levamisole hydrochloride gel.
Section 520.1242g - Levamisole resinate and famphur paste.
Section 520.1263 - Lincomycin hydrochloride monohydrate oral dosage forms.
Section 520.1263a - Lincomycin hydrochloride monohydrate tablets and sirup.
Section 520.1263b - Lincomycin hydrochloride monohydrate and spectinomycin sulfate tetrahydrate soluble powder.
Section 520.1263c - Lincomycin hydrochloride soluble powder.
Section 520.1284 - Sodium liothyronine tablets.
Section 520.1288 - Lufenuron tablets.
Section 520.1289 - Lufenuron suspension.
Section 520.1310 - Marbofloxacin tablets.
Section 520.1320 - Mebendazole oral.
Section 520.1326 - Mebendazole and trichlorfon oral dosage forms.
Section 520.1326a - Mebendazole and trichlorfon powder.
Section 520.1326b - Mebendazole and trichlorfon paste.
Section 520.1330 - Meclofenamic acid granules.
Section 520.1331 - Meclofenamic acid tablets.
Section 520.1341 - Megestrol acetate tablets.
Section 520.1380 - Methocarbamol tablets.
Section 520.1390 - (S)-methoprene.
Section 520.1408 - Methylprednisolone tablets.
Section 520.1409 - Methylprednisolone, aspirin tablets.
Section 520.1422 - Metoserpate hydrochloride.
Section 520.1430 - Mibolerone.
Section 520.1445 - Milbemycin oxime tablets.
Section 520.1446 - Milbemcyin oxime/lufenuron tablets.
Section 520.1448 - Monensin oral dosage forms.
Section 520.1448a - Monensin blocks.
Section 520.1450 - Morantel tartrate oral dosage forms.
Section 520.1450a - Morantel tartrate bolus.
Section 520.1450b - Morantel tartrate cartridge.
Section 520.1450c - Morantel tartrate sustained-release trilaminate cylinder/sheet.
Section 520.1451 - Moxidectin.
Section 520.1452 - Moxidectin gel.
Section 520.1468 - Naproxen granules.
Section 520.1484 - Neomycin sulfate soluble powder.
Section 520.1485 - Neomycin sulfate oral solution.
Section 520.1510 - Nitenpyram.
Section 520.1615 - Omeprazole.
Section 520.1616 - Orbifloxacin tablets.
Section 520.1628 - Oxfendazole powder and pellets.
Section 520.1629 - Oxfendazole paste.
Section 520.1630 - Oxfendazole suspension.
Section 520.1631 - Oxfendazole and trichlorfon paste.
Section 520.1638 - Oxibendazole paste.
Section 520.1640 - Oxibendazole suspension.
Section 520.1660 - Oxytetracycline.
Section 520.1660a - Oxytetracycline and carbomycin in combination.
Section 520.1660b - Oxytetracycline hydrochloride capsules.
Section 520.1660c - Oxytetracycline hydrochloride tablets/boluses.
Section 520.1660d - Oxytetracycline hydrochloride soluble powder.
Section 520.1696 - Penicillin oral dosage forms.
Section 520.1696a - Buffered penicillin powder, penicillin powder with buffered aqueous diluent.
Section 520.1696b - Penicillin G potassium in drinking water.
Section 520.1696c - Penicillin V potassium for oral solution.
Section 520.1696d - Penicillin V potassium tablets.
Section 520.1720 - Phenylbutazone oral dosage forms.
Section 520.1720a - Phenylbutazone tablets and boluses.
Section 520.1720b - Phenylbutazone granules.
Section 520.1720c - Phenylbutazone paste.
Section 520.1720d - Phenylbutazone gel.
Section 520.1802 - Piperazine-carbon disulfide complex oral dosage forms.
Section 520.1802a - Piperazine-carbon disulfide complex suspension.
Section 520.1802b - Piperazine-carbon disulfide complex boluses.
Section 520.1802c - Piperazine-carbon disulfide complex with phenothiazine suspension.
Section 520.1803 - Piperazine citrate capsules.
Section 520.1804 - Piperazine phosphate capsules.
Section 520.1805 - Piperazine phosphate with thenium closylate tablets.
Section 520.1806 - Piperazine monohydrochloride liquid.
Section 520.1807 - Piperazine.
Section 520.1840 - Poloxalene.
Section 520.1846 - Polyoxyethylene (23) lauryl ether blocks.
Section 520.1870 - Praziquantel tablets.
Section 520.1871 - Praziquantel/pyrantel pamoate tablets.
Section 520.1872 - Praziquantel, pyrantel pamoate, and febantel tablets.
Section 520.1880 - Prednisolone tablets.
Section 520.1900 - Primidone tablets.
Section 520.1920 - Prochlorperazine, isopropamide sustained release capsules.
Section 520.1921 - Prochlorperazine, isopropamide, with neomycin sustained-release capsules.
Section 520.1962 - Promazine hydrochloride.
Section 520.2002 - Propiopromazine hydrochloride.
Section 520.2041 - Pyrantel pamoate chewable tablets.
Section 520.2042 - Pyrantel pamoate tablets.
Section 520.2043 - Pyrantel pamoate suspension.
Section 520.2044 - Pyrantel pamoate paste.
Section 520.2045 - Pyrantel tartrate powder; pyrantel tartrate pellets.
Section 520.2087 - Roxarsone soluble powder.
Section 520.2088 - Roxarsone tablets.
Section 520.2089 - Roxarsone liquid.
Section 520.2095 - Sarafloxacin soluble powder.
Section 520.2098 - Selegiline hydrochloride tablets.
Section 520.2100 - Selenium, vitamin E capsules.
Section 520.2122 - Spectinomycin dihydrochloride oral solution.
Section 520.2123 - Spectinomycin dihydrochloride pentahydrate oral dosage forms.
Section 520.2123a - Spectinomycin dihydrochloride pentahydrate tablets.
Section 520.2123b - Spectinomycin dihydrochloride pentahydrate soluble powder.
Section 520.2150 - Stanozolol oral dosage forms.
Section 520.2150a - Stanozolol tablets.
Section 520.2150b - Stanozolol chewable tablets.
Section 520.2158 - Streptomycin/dihydrostreptomycin oral dosage forms.
Section 520.2158a - Streptomycin sulfate oral solution.
Section 520.2158b - Dihydrostreptomycin tablets.
Section 520.2158c - Dihydrostreptomycin oral suspension.
Section 520.2160 - Styrylpyridinium, diethylcarbamazine oral dosage forms.
Section 520.2170 - Sulfabromomethazine sodium boluses.
Section 520.2184 - Sodium sulfachloropyrazine monohydrate.
Section 520.2200 - Sulfachlorpyridazine oral dosage forms.
Section 520.2200a - Sulfachlorpyridazine bolus.
Section 520.2200b - Sulfachlorpyridazine medicated milk and drinking water.
Section 520.2200c - Sulfachlorpyridazine tablets.
Section 520.2220 - Sulfadimethoxine oral dosage forms.
Section 520.2220a - Sulfadimethoxine oral solution and soluble powder.
Section 520.2220b - Sulfadimethoxine tablets and boluses.
Section 520.2220c - Sulfadimethoxine oral suspension.
Section 520.2220d - Sulfadimethoxine-ormetoprim tablets.
Section 520.2240 - Sulfaethoxypyridazine.
Section 520.2240a - Sulfaethoxypyridazine drinking water.